A new horizon of moyamoya disease and associated health risks explored through RNF213

Area of Science:

• Genetics
• Neurology
• Epidemiology

Background:

• Moyamoya disease (MMD) is a cerebrovascular disorder primarily affecting children, causing stroke.
• While historically considered Asian-specific, MMD is a global health concern.
• The RNF213 gene is identified as a key susceptibility gene for MMD.

Purpose of the Study:

• To review the genetics and epidemiology of RNF213 in MMD.
• To explore the pathology and molecular functions of the RNF213 gene.
• To address public health aspects and ethical considerations in MMD research.

Main Methods:

• Literature review focusing on RNF213 genetics, epidemiology, and molecular function.
• Analysis of RNF213 variants, particularly the p.R4810K mutation.
• Discussion of MMD definition, cohort studies, and genetic testing ethics.

Main Results:

• RNF213 is strongly associated with MMD, particularly the p.R4810K variant common in Asian populations.
• RNF213 exhibits unique characteristics, including MMD induction without other phenotypes and dual enzymatic activities.
• Carrier rates for the RNF213 p.R4810K variant are significant (0.5-2%) but show low penetrance.

Conclusions:

• Further research into RNF213 is essential for understanding MMD pathogenesis.
• Updated MMD definitions and robust genetic epidemiology studies are needed.
• Ethical considerations surrounding genetic testing for MMD susceptibility require careful attention.